Journal of Dermatological Science
Volume 30, Issue 2 , Pages 94-99 , November 2002

Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis

Received 25 March 2002 ,Revised 29 May 2002 ,Accepted 3 June 2002.

References 

  1. Yoshikawa K, Adachi K, Halprin KM, Levine V. On the luck of response to cathecholamine stimulation by the adenyl cyclase system in psoriatic lesions. Br. J. Dermatol. 1975;92:619–624
  2. Iizuka H, Adachi K, Halprin KM, Levine V. Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and epinephrine by the uninvolved and involved epidermis. J. Invest. Dermatol. 1978;70:250–253
  3. Horn F, Marks F, Fisher GJ, Marcelo CL, Voorhees JJ. Decreased protein kinase C activity in psoriatic versus normal epidermis. J. Invest. Dermatol. 1987;88:220–222
  4. Furstenberger G, Schweizer J, Marks F. Development of phorbol ester responsiveness in neonatal mouse epidermis: correlation between hyperplastic response and sensitivity to first stage tumor promotion. Carcinogenesis. 1985;6:289–294
  5. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 1993;260:315–319
  6. Sachsenmaier C, Radler-Pohl A, Zinck R, Nordheim A, Herrlich P, Rahmsdorf HJ. Involvement of growth factor receptors in the mammalian UVC response. Cell. 1994;78:963–972
  7. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al.  A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994;78:1027–1037
  8. Minden A, Lin A, Claret F, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPase Rac and Cdc42Hs. Cell. 1995;81:1147–1157
  9. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, et al.  The small GTP-binding proteins Rac1 and Cdc 42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 1995;81:1137–1146
  10. Efimova T, LaCelle P, Welter JF, Eckert RL. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP-1 signal transduction pathway. J. Biol. Chem. 1998;273:24387–24395
  11. Takahashi H, Honma M, Ishida-Yamamoto A, Namikawa K, Kiyama H, Iizuka H. Human cystatin A expression of keratinocytes is positively regulated by Ras/MEKK1/MKK7/JNK signal transduction pathway and negatively regulated by Ras//Raf-1/MEK1ERK pathway. J. Biol. Chem. 2001;276:36632–36638
  12. Haase I, Hobbs RM, Romero R, Broad S, Watt FM. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J. Clin. Invest. 2001;108:527–536
  13. Dimon-Gadal S, Raynaud F, Evain-Broin D, Keryer G. MAP kinase abnormalities in hyperproliferative cultured fibroblasts from psoriatic skin. J Invest Dermatol. 1998;110:872–879
  14. Dover R, Watt FM. Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J. Invest. Dermatol. 1987;89:349–352
  15. Tezuka T, Qing J, Saheki M, Kusuda S, Takahashi M. Terminal differentiation of facial epidermis of the aged: immunohistochemical studies. Dermatology. 1994;188:21–24
  16. Hohl D. Expression patterns of loricrin in dermatological disorders. Am. J. Dermatopathol. 1993;15:20–27
  17. Schroeder WT, Thacher SM, Stewart-Galekka S, Annarella M, Chema D, Siciliano MJ, et al.  Type I keratinocyte transglutaminase: expression in human skin and psoriasis. J. Invest. Dermatol. 1992;99:27–34
  18. Pfundt R, Wingens M, Bergers M, Zweers M, Frenken M, Schalkwijk . TNF-α and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch. Dermatol. Res. 2000;292:180–187
  19. Iizuka H, Ishida-Yamamoto A, Honda H. Epidermal remodeling in psoriasis. Br. J. Dermatol. 1996;135:433–438
  20. Iizuka H, Honda H, Ishida-Yamamoto A. Epidermal remodeling in psoriasis (II): a quantitative analysis of the epidermal architecture. J. Invest. Dermatol. 1997;109:806–810
  21. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ, et al.  Overexpression of transforming growth factor alpha in psoriatic epidermis. Science. 1989;243:811–814
  22. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGFα during epidermal development and differentiation. Genes Dev. 1991;5:714–727
  23. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey JM, Shipley GD. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 1992;52:3224–3227
  24. Cook PW, Piepkorn M, Clegg CH, Plowman GD, Demay JM, Brown JR, et al.  Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 1997;100:2286–2294
  25. Nakamura S, Takahashi H, Kinouchi M, Manabe A, Ishida-Yamamoto A, Hashimoto Y, et al.  Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes. J. Dermatol. Sci. 2001;25:139–149

PII: S0923-1811(02)00064-6

Journal of Dermatological Science
Volume 30, Issue 2 , Pages 94-99 , November 2002

Article Tools

* Image Usage & Resolution